| Literature DB >> 31315942 |
Frank van Drogen1, Ranjan Mishra2, Fabian Rudolf2, Michal J Walczak3, Sung Sik Lee2,4, Wolfgang Reiter5, Björn Hegemann2, Serge Pelet6, Ilse Dohnal5, Andres Binolfi7, Zinaida Yudina2, Philipp Selenko7, Gerhard Wider3, Gustav Ammerer5, Matthias Peter8.
Abstract
Cells continuously adapt cellular processes by integrating external and internal signals. In yeast, multiple stress signals regulate pheromone signaling to prevent mating under unfavorable conditions. However, the underlying crosstalk mechanisms remain poorly understood. Here, we show that mechanical stress activates Pkc1, which prevents lysis of pheromone-treated cells by inhibiting polarized growth. In vitro Pkc1 phosphorylates conserved residues within the RING-H2 domains of the scaffold proteins Far1 and Ste5, which are also phosphorylated in vivo. Interestingly, Pkc1 triggers dispersal of Ste5 from mating projections upon mechanically induced stress and during cell-cell fusion, leading to inhibition of the MAPK Fus3. Indeed, RING phosphorylation interferes with Ste5 membrane association by preventing binding to the receptor-linked Gβγ protein. Cells expressing nonphosphorylatable Ste5 undergo increased lysis upon mechanical stress and exhibit defects in cell-cell fusion during mating, which is exacerbated by simultaneous expression of nonphosphorylatable Far1. These results uncover a mechanical stress-triggered crosstalk mechanism modulating pheromone signaling, polarized growth, and cell-cell fusion during mating.Entities:
Year: 2019 PMID: 31315942 PMCID: PMC6719448 DOI: 10.1083/jcb.201808161
Source DB: PubMed Journal: J Cell Biol ISSN: 0021-9525 Impact factor: 10.539
Figure 1.Pkc1 protects cells from lysis upon mechanostress during pheromone exposure through inhibition of the mating pathway. (A) Haploid mating-type a WT cells were exposed to α-factor for 100 min, followed by 15-min pretreatment with DMSO or 7.5 µM of the Pkc1 inhibitor cercosporamide (cerc.). Then, mechanostress or no stress was applied for 30 min. Lysis of shmooing cells was visualized by phase-contrast microscopy and staining with Trypan blue dye. (B) Quantification of cell lysis in shmooing WT cells, treated as in A; >150 cells in at least three independent experiments were quantified for each condition and shown as percentage of lysed cells. Error bars indicate SEM, and significance was determined by t test (*, P ≤ 0.05; **, P ≤ 0.01; ***, P ≤ 0.001). (C) Quantification of cell lysis in shmooing WT cells harboring or not (control) a plasmid expressing dominant-negative Pkc1 (Pkc1K853R) from the inducible GAL1 promoter. Cells growing in log phase in 2% raffinose were induced with 2% galactose for 2 h followed by exposure to α-factor for 100 min. Mechanostress was applied and cell lysis analyzed as described in B. (D) WT cells expressing the Fus3 SKAR and Hta2-CFP reporters were treated with pheromone and 7.5 µM cercosporamide (cerc.) as in A. Nuclear accumulation of the Fus3 SKAR reporting Fus3 activity after 30 min of mechanostress was monitored microscopically and quantified in ≥150 cells in three independent experiments. Error bars indicate SEM, and significance was determined by a t test (*, P ≤ 0.05). Representative images before and after mechanostress are shown below. (E) WT cells expressing the Fus3 SKARS and Hta2-CFP reporters were treated with pheromone and subsequently with 7.5 µM cercosporamide (cerc.) as described in A, and Fus3 activity was quantified in lysing and protected cells. Cells failing to relocalize the reporter to the nucleus under mechanostress were scored as high Fus3 activity; ≥150 cells were analyzed for each condition in three independent experiments and are shown as percentage of high or low Fus3 activity. Error bars indicate SEM. Note that cells unable to down-regulate Fus3 activity are prone to cell lysis. (F) WT cells expressing the chemically inhibitable Fus3-as allele from the endogenous locus were treated with α-factor for 100 min followed by pretreatment with 7.5 µM cercosporamide (cerc.) and 5 µM NaPP1. Then mechanostress was applied. Lysis of ≥150 pheromone-responsive cells was scored for each condition in three independent experiments and is shown as percentage of lysed cells. Error bars indicate SEM, and significance was determined by a t test (***, P ≤ 0.001). (G) Quantification of cell lysis upon mechanostress in WT or mpk1Δ cells treated as in B. At least 150 cells in at least three independent experiments were analyzed for each condition and are shown as percentage of lysed cells. Error bars indicate SEM, and significance was verified by a t test (**, P ≤ 0.01; ***, P ≤ 0.001). Genetic background and growth conditions in this experiment are the same as in B, and thus, the data for the WT conditions were combined. (H) Cells expressing Ste5-tV under its endogenous promotor in WT or mpk1Δ cells were treated as in A, and Ste5-tV was visualized microscopically in microfluidic chips during 30 min of mechanostress. Loss of Ste5-tV at shmoo tips was quantified in ≥150 cells for each condition in at least three independent experiments, and shown as percentage of cells with dispersed Ste5 localization. Error bars indicate SEM and significance was validated by a t test (**, P ≤ 0.01; ***, P ≤ 0.001). (I) Pkc1-dependent signaling protects mating cells against mechanostress. Pkc1 triggers loss of Ste5 from shmoo tips by an Mpk1-independent mechanism, leading to reduced Fus3 activity.
Figure 2.Serine 185 within the RING-H2 domain of Ste5 is phosphorylated by Pkc1. (A) Schematic of Ste5 functional domains. MAPK, MAPK docking site; VWA, von Willebrand factor type A domain. Phosphorylated sites identified by MS analysis (localization probability >0.75 according to MaxQuant) in cells exposed to α-factor after phosphopeptide enrichment on a TiO2 column are indicated by tick marks. The RING domain sequence is aligned with those of different yeast Ste5 proteins and the RING domain of S. cerevisiae Far1. Ser185 of S. cerevisiae is indicated in bold red and conserved in other yeast species. An analogous serine residue (Ser210) located within the Far1 RING domain (bold red) is also phosphorylated, together with two lower confidence sites (red; Ser208 and Ser211). (B) Recombinant 6His-tagged Ste5- and Far1-RING-H2 fragments were incubated for 30 min at 30°C with GST-Pkc1 purified from yeast extracts containing γ32P-ATP with (+) or without (−) 30 µM cercosporamide (cerc.). Phosphorylated proteins were visualized by autoradiography. An aliquot of purified Ste5- and Far1-RING-H2 fragments were separated by SDS-PAGE and stained with Coomassie blue. The bar points to the 35-kD size marker. (C–F) In vitro kinase assays using either WT or the nonphosphorylatable S185A mutant RING-H2 domain with amino acids 149–238 of Ste5 (Ste5149−238) as a substrate and incubated as indicated with yeast extracts in the absence (DMSO) or presence of cercosporamide were analyzed by 600 MHz 1H-15N correlation NMR spectra (SOFAST HMQC; Schanda et al., 2005). The resonance position of the phosphorylated Ser185 amide group is magnified in C and highlighted in the dashed circle in D–F. The spectra in C are an overlay of the Ste5-RING-H2 fragment incubated with (black) or without (red) Pkc1. (G) M-track protein–protein proximity assays using extracts of cells expressing HKMT-myc–tagged Ste5 (bait) and protA-H3–tagged Pkc1 (prey). Cells were treated with α-factor for the times indicated (hours). Proximity signals were detected by Western blotting using an antibody against triple-methylated lysine of histone H3 (α-me). Loading was controlled via a hemagglutinin epitope embedded in the protA-H3 tag (α-HA). The asterisk marks an unspecific band.
Figure 3.Phosphorylation of the RING-H2 domains of Ste5 and Far1 inhibits signaling and oriented cell polarity. (A) Extracts prepared from ste5Δ cells expressing 3xGFP-tagged WT Ste5, nonphosphorylatable Ste5S185A, or phospho-mimicking Ste5S185D or harboring an empty control plasmid were analyzed by immunoblotting using anti-GFP antibodies. Pgk1 controls equal loading. (B) Halo assays were used to assess cell cycle arrest in response to α-factor for ste5Δ cells expressing Ste5 and control constructs as in A. (C) Pheromone-dependent gene expression of ste5Δ cells harboring a FIG1-qV reporter and the indicated WT Ste5 (diamond), Ste5S185A (square), or Ste5S185D (triangle) was determined by FACS analysis and plotted in arbitrary units at the times indicated (minutes) after α-factor addition. (D) Microfluidic chambers generated a 0–80-nM α-factor gradient. The angle of the polarity site with respect to the α-factor gradient (schema) was measured for far1Δ strains expressing WT Far1, nonphosphorylatable Far13A, or phospho-mimicking Far13E. Results are expressed as percentages and binned into 45° incremental distances (Hegemann et al., 2015).
Figure 4.Phosphorylation of serine 185 interferes with membrane recruitment of Ste5 and prevents Gβγ binding. (A) The localization of 3xGFP-tagged WT Ste5 (upper panel), Ste5S185A (middle panel), or Ste5S185D (lower panel) expressed in WT cells exposed to α-factor was analyzed by light microscopy. The percentage of cells with accumulated GFP-signal at shmoo tips was quantified by counting ≥100 cells for each strain. (B) Recruitment of 3xGFP-tagged WT Ste5, Ste5S185A or Ste5S185D was quantified in single cells at the indicated times upon addition of α-factor (t = 0). The membrane-to-cytoplasmic ratio was calculated using YeastQuant (Pelet et al., 2012) using TMD-mCherry to segment the plasma membrane. The solid line represents the median of the single-cell traces and the shaded area the 25th–75th percentiles. (C) FIG1-qV reporter expression was measured by FACS in ste5Δ cells expressing from the estradiol-inducible GAL promoter WT Ste5 (diamond), nonphosphorylatable Ste5S185A (square), or phospho-mimicking Ste5S185D (triangle) fused to a TMD and plotted in arbitrary units for different estradiol concentrations. For control, WT Ste5 (x) and Ste5S185D (*) were also expressed without TMD fusion. (D) GST-Ste4–Ste18 purified from yeast was immobilized on glutathione-Sepharose beads and incubated in vitro with either 6His-tagged Ste5 WT (Ste5149–238) or S185D (Ste5149–238 S185D) RING domains expressed in E. coli. Bound and flow-through fractions were collected and analyzed by Western blotting with the indicated antibodies. +, protein added; −, protein omitted. An aliquot of the input fraction controls for the presence of the specified proteins. GST-Ste4–Ste18 preferentially binds to the nonphosphorylated Ste5-RING domain. (E) Overlay of [1H, 15N] correlation spectra of WT (left panel), S185A (middle panel), and S185D (right panel) Ste5 RING-H2 domain in free form (black contours) and in complex with Gβγ subunits (red). Ste5 adopts a better-defined fold upon binding Gβγ binding with larger peak dispersion. In contrast to WT and the S185A mutant, the S185D RING-H2 domain fails to interact with Gβγ heterodimers.
Figure 5.Pkc1-dependent phosphorylation of Ste5-Ser185 inhibits signaling and prevents lysis during mechanostress. (A and B) Expression of the FIG1-qV reporter was measured by FACS in ste5Δ cells expressing GFP-tagged WT Ste5 (diamond), Ste5S185A (square), or Ste5S185D (triangle) and plotted in arbitrary units at the times after addition of α-factor. The cells were transformed with a plasmid expressing either WT (Pkc1, A) or dominant-active (Pkc1R398A, B) Pkc1 from the inducible GAL1-promoter for 2 h. Expression of Pkc1R398A inhibits pheromone signaling in a Ste5Ser185-dependent manner. (C) Cell lysis upon mechanostress in cells expressing WT Ste5 or Ste5S185A mutant was analyze in cells treated as in Fig. 1 A; ≥150 shmooing cells from three independent experiments were analyzed for each condition and are shown as percentage of lysed cells. The error bars indicate SEM, and significance was validated with a t test (*, P ≤ 0.05; **, P ≤ 0.01; ***, P ≤ 0.001). (D) Dispersal of either tV-tagged WT Ste5 or Ste5S185A from shmoo tips upon mechanostress in cells treated as in Fig. 1 A. Loss of Ste5-tV at shmoo tips was quantified in ≥150 cells from three independent experiments for each condition and is shown as percentage of cells with dispersed Ste5 localization. The error bars indicate SEM, and significance was validated with a t test (**, P ≤ 0.01; ***, P ≤ 0.001).
Figure 6.Pkc1 prevents cell lysis by promoting membrane dissociation of Ste5 and Far1 upon cell–cell fusion. (A) The relative mating efficiency of ste5Δ cells expressing either WT Ste5 or Ste5S185A was measured in media where only diploid cells can grow. The SD was determined from at least three experiments. (B) Schematic of the microfluidic device used to observe the mating process. Cells were captured in pockets (magnified inset) and imaged by live-cell microscopy. The pillar array (1,008 traps/array) allows one to trap cells and visualize mating. (C and D) Zygotes resulting from the indicated crosses were followed after fusion and scored for cell lysis by microscopy. (C) The percentage of viable diploids is plotted as a function of time after cell–cell fusion; ≥100 zygotes from three different experiments were analyzed for each cross. The error bars indicate SD of three independent experiments, and significance was determined for the 150-min time point by a t test (*, P ≤ 0.05; **, P ≤ 0.01; ***, P ≤ 0.001). (D) Zygotes were assessed for emergence of their first bud after fusion event. Box and whisker plots show median and first and third quartiles, with the outlier 5th and 95th percentiles indicated as symbols (filled circles). Significance was determined by ANOVA and a t test (*, P ≤ 0.05; **, P ≤ 0.01). (E) 3xGFP-tagged Ste5 expressed in MATa cells was localized by fluorescence microscopy during cell–cell fusion with unlabeled MATα-partners. Images were taken at the indicated times with t = 0 defined when cell–cell contact is detected. Successful cell–cell fusion was monitored by the appearance of GFP-tagged proteins in the unlabeled mating partner. (F and G) The levels of 3xGFP-tagged WT Ste5 and Ste5S185A at the site of cell–cell fusion were quantified, and relative intensity with SD compared with the cytoplasmic signal as a function of time was plotted (F). t = 0 was defined as cell–cell fusion, monitored by the appearance of GFP-tagged proteins in the unlabeled mating partner. Zygotes were assessed for the time of localized GFP residence. The error bars indicate SD of three independent experiments, and significance was determined by a t test at the indicated time points (*, P ≤ 0.05). (G) Box and whisker plots show median and first and third quartiles, with the outlier 5th and 95th percentiles indicated as symbols (filled circles); ≥70 cells were analyzed, and a t test was used to determine significance (*, P ≤ 0.05).
Yeast strains
|
|
|
|
|
|---|---|---|---|
| BY4741 | MAT | OpenBiosystems | Parental |
| w303 | leu2-3,112 trp1-1 can1-100 ura3-1 ade2-1 his3-11,15 | Lab collection | Parental |
| yRM119 | BY4741 Prps2-Ste7DS(1-30)-2xNLS(9SP)-Cherry:: |
| |
| yRM120 | BY4741 |
| Fig. S2 A |
| yRM230 | BY4741 Bni1-qV:: |
|
|
| yRM242 | w303 ste5Δ:: | This study | |
| yRM243 | w303 | This study |
|
| yRM244 | yRM242 | This study | |
| yRM251 | yRM242 empty - | This study | Fig. S2 G |
| yRM252 | yRM242 | This study | Fig. S2 G |
| yRM253 | BY4741 | Collection | Fig. S1 B |
| yRM254 | BY4741 | Collection | Fig. S1 C |
| WR232 | w303 SILAC STE5-HTBn:: | This study, W303 SILAC background described in | |
| WR254 | w303 SILAC FAR1-HTBeaq:: | This study | |
| WR484 | w303 SILAC STE5-HTBn:: | This study | |
| WR658 | w303 SILAC Ste5HTBnp:: | This study | |
| WR725 | w303 Ste5-HTBn:: | This study | |
| WR800 | w303 SILAC STE5-HTB:: | This study | |
| JA596 | w303 STE5-HKMT-myc:: | This study |
|
| YFD230 | w303 ste5Δ:: | This study | Parental |
| yFD702 | w303 ste5Δ:: | This study |
|
| ySP85 | w303 ste5Δ:: | This study |
|
| ySP86 | w303 ste5Δ:: | This study |
|
| ySP296 | w303 ste5Δ:: | This study | Parental |
| ySP309 | w303 Fig1qV:: | This study | Parental |
| ySP323 | w303 ste5Δ:: | This study | |
| ySP331 | w303 Hta2-mCherry:: | Lab collection | Fig. S2 B |
| ySR8 | w303 ste5Δ:: | This study | |
| ySR112 | w303 ste5Δ:: | This study | |
| ySR116 | w303 ste5Δ:: | This study | |
| yBH56 | BY4741 far1Δ::Far1-HA-2xStrp::Ca | This study | |
| yBH80 | BY4741 far1Δ::Far13A S208S210S211-HA-2xStrp::Ca | This study |
|
| yBH90 | BY4741 far1Δ::Far13E S208S210S211-HA-2xStrp::Ca | This study |
|
| L40 | AOP- | Lab collection | Fig. S5, A and B |
| yIS153 | W303a TMD-cherry-pRPS2:: | This study |
|
| yIS155 | w303a TMD-cherry-pRPS2:: | This study |
|
| yIS156 | w303a TMD-cherry-pRPS2:: | This study |
|
| yIS158 | w303alpha | This study |
|
| yIS159 | w303alpha | This study |
|
| yIS163 | w303alpha | This study |
|
Plasmids
|
|
|
|
|
|---|---|---|---|
| pNVT-ST-149–238 | 6His-Ste5-RING-H2149–238 |
| |
| pNVT-ST-149–238 S185A | 6His-Ste5-RING-H2149–238 S185A | This study | |
| pNVT-ST-149–238 S185D | 6His-Ste5-RING-H2149–238 S185D | This study |
|
| pNVT-FR-RING-H2 | 6His-Far1-RING-H2173-261 | This study |
|
| pMG270 | pRD53 GAL1 PKCR398A | Collection | |
| pMG269 | pRD53 GAL1 PKCK853R | Collection |
|
| pGADXP | 2 µm LEU2 ADH1pr GAL4 AD | Lab collection | Fig. S5, A and B |
| pBH13 | lexA DBD HA-Far1174–285 | This study | Fig. S5, A and B |
| pBH14 | GAL4 AD HA-Ste4 | Fig. S5, A and B | |
| pBH65 | lexA DBD HA-Far1174–285 3A S208S210S211 | This study | Fig. S5, A and B |
| pBH67 | lexA DBD HA-Far1174–285 3D S208S210S211 | This study | Fig. S5, A and B |
| pSP151 | pRS316 endo-Ste5S185A-3xGFP | This study | |
| pSP167 | pRS303 pGAL1-Ste5S185D-TMD | This study |
|
| pSP169 | pRS303 pGAL1-Ste5S185A-TMD | This study |
|
| pSP174 | pRS316 endo-Ste5S185D-3xGFP | This study |
|
| pSP175 | pRS316 endo-Ste5-3xGFP | This study | |
| pSP186 | pRS303 endo-Ste5-13myc | This study |
|
| pSP188 | pRS303 endo-Ste5S185D-13myc | This study |
|
| pSP193 | Msn2p-NLS-GFP (pPKI-NESMsn2p(567–704)-GFP) LEU2 |
| Fig. S1 D |
| pFD344 | pRS303 pGAL1-Ste5-TMD | This study |
|
| pFD532 | GAL1-GST-Pkc1 | Collection |
|
| pFD720 | pRS426 pGAL1-GST-Ste18–Ste4 | This study |
|